⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
UCB News
United Community Banks, Inc.
Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
globenewswire.com
ABBV
AZN
BIIB
BMY
GSK
LLY
MRK
NVS
SNY
TEVA
UCB
United Community Earns 12th JD Power Award in 17 Years, Ranked #1 for Retail Banking Customer Satisfaction in the Southeast Region
prnewswire.com
UCB
UCB Selects Rowen for $2B Biopharmaceutical Manufacturing Campus
prnewswire.com
UCB
UCB Selects Georgia for New U.S. Biologics Manufacturing Facility; ~$5B Economic Impact and ~330 Permanent Jobs
prnewswire.com
UCB
Bavarian Nordic A/S – Notice Convening Annual General Meeting
globenewswire.com
JNJ
UCB
GSK
SNY
VICR
IOBT
FLS
IQV
PANTHERx® Rare Selected by UCB as the Exclusive Specialty Pharmacy for the Distribution of KYGEVVI™
prnewswire.com
UCB
BIMZELX®▼(bimekizumab) superior to SKYRIZI® (risankizumab) in BE BOLD: first head-to-head study in active psoriatic arthritis (PsA) to demonstrate superiority in ACR50
prnewswire.com
UCB
Bimzelx (UCB) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
UCB
Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases USA - English APAC - English USA - English
prnewswire.com
UCB
Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases USA - English USA - English APAC - English
prnewswire.com
UCB